205 Users Online
Surgical and Respiratory Masks Market by Product (Surgical Masks, Respirator)
The Global revenue from the Surgical and Respiratory Masks Market was valued at US$ 3.57 Billion in 2022, with the global market estimated to surge ahead at a CAGR of 8.1% to reach a valuation of US$ 8.41 Billion by the end of 2033.
|
Market Size (2023) |
US$ 3.85 Billion |
|
Projected Market Value (2033) |
US$ 8.41 Billion |
|
Global Market Growth Rate (2023 to 2033) |
8.1% CAGR |
|
Market Share of Top 5 Countries |
63.7% |
As assessed by Persistence Market Research, surgical masks held a market share of around 52.4% in the global market, in 2022. The global surgical and respiratory masks market holds nearly 10.7% revenue share of the global respiratory protection equipment market valued at US$ 3.57 Billion in 2022
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global market recorded a historic CAGR of 6.9% in the last 7 years from 2015 to 2022.
The global market is likely to show high growth over the coming years at a CAGR of 8.1% to reach a global market size of 8.41 Billion by 2033.
Respirators and surgical masks are examples of personal protective equipment that are used to protect the wearer from particles or from liquid contaminating the face. The Centres for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) also regulate N95 respirators. The Department of Labour’s Occupational Safety and Health Administration (OSHA) regulates entities for compliance with worker safety rules and OSHA standards, including, for example, the proper use of respirators in different work environments.
Surgical masks and respirator masks serve distinct functions; they are designed differently. Surgical masks are small pieces of cloth that people wear to keep germs from their coughs and sneeze themselves, or to avoid contracting other people's viruses and bacteria. It's essentially a physical barrier that prevents large amounts of fluid from entering the human mouth.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version“Transcending pandemic, non–communicable diseases and others to accelerate the surgical and respiratory masks market growth”
The tolls of infections and deaths by a pandemic are escalating its havoc at a global scale, along with the surging prevalence of non–communicable diseases (NCD) such as diabetes, cancer, cardiac diseases, and other contrives towards surgical procedures.
In 2020, World Health Organization WHO estimates that more than 15 million persons aged 30 to 69 die from an NCD every year; low– and middle–income nations account for 85% of these "premature" deaths and are also thrusting the market growth, globally.
Several respiratory complications make people vulnerable to rising air pollution, which can lead to death. The World Health Organization (WHO) states that global influenza activity increased, and the influenza A(H3N2) virus subtype became dominant. 15,723 specimens out of 229,940 tested positive for influenza viruses in 2022. The proportions of influenza A and influenza B viruses were 14,589 (92.8%) and 1134 (7.2%), respectively. Respiratory masks, with their advanced fine filters that disallow smoke, ashes, bacteria, and even viruses in the size range of 10 to 80 nm, are thus a promising option for protection from air pollution, smog, and microbes.
“The massive and rational usage of the surgical and respiratory mask”
Due to the lack of medication available for the deadly virus, the global havoc of the pandemic has made the use of surgical and respiratory masks instrumental during the crisis. These masks have become an essential part of daily life, and they can be found in schools, hospitals, and other public places. Surgical and respiratory masks amid a coronavirus pandemic are non–pharmaceutical intervention (NPI) measures to effectively protect against viruses such as flu viruses at low cost. These masks reduce the risk of transmission, dampen the aerosol rate, provide population coverage, and are available to the general public.
According to the study on Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic 2020, published in Nature Communication, even limited distribution of masks provided only 25% protection, and containment resulted in a significant reduction; 10% population of adoption could result in 5% fewer deaths. As a result, the acceptance of masks to prevent virus transmission was gaining traction.
“New product launches fuelling the surgical and respiratory masks market growth.”
Manufacturers of surgical and respiratory masks are focusing their R&D and product launches with deliberate efforts toward innovative, safer, and advanced protections, as well as comfort, such as overcoming the hindrance caused by conventional masks. In 2022, Honeywell, for example, introduced two new respiratory protection solutions for healthcare professionals. The Honeywell DC365 Small Surgical N95 Respirator was created to protect frontline workers who require a smaller surgical N95.
“Rising prevalence of respiratory illnesses is expected to raise opportunities in the market.”
The increased incidence of COVID, the flu, and RSV is anticipated to have a beneficial effect on the global market for surgical and respiratory devices. For example, on December 5, 2022, the Centers for Disease Control and Prevention advised individuals to use masks to help prevent the transmission of respiratory infections this season as the flu, Covid, and RSV are all contagious at the same time. The CDC director stated that the organization is thinking of extending its Covid community levels approach to account for other respiratory infections like the flu. The method serves as the foundation for the CDC's recommendations for mask use.
“High production cost and current limitations in patient scalability”
The decline in the use of respiratory masks is due to the drop in the new covid cases and widespread vaccination around the world. the governments are easing the rules for the public saying that no need for wearing masks. For instance, Italy drops covid face mask rule for public transport.
similarly, the environmental damage by disposable masks hampers the growth of the market. The disposable face masks could pose an ongoing risk to wildlife for ten to hundreds of years.
According to the study on the Lifecycle environmental impacts of disposable medical masks submitted in springer, the global warming potential of disposable medical masks supplied in 2020 is 1.1 Mt CO2 eq. Globally, the textile industry emits 1.2 billion tonnes of CO2 eq. per year.
Sales Team
Client Partner
Why is the United States Market Booming?
“Rising incidence of flu and RSV in the country to rise the demand for respiratory masks”
The United States accounted for around 31.6% market share in the global market in 2022.
According to the Centers for Disease Control and Prevention (CDC), the United States is experiencing a flu epidemic in 2022. As cases grow and new varieties emerge, the country also confronts a triple epidemic of the flu, respiratory syncytial virus (RSV) in young children, and covid–19. The CDC estimates that at least 1 600 000 illnesses, 13 000 hospital admissions, and 730 flu-related fatalities have occurred so far this season.
Some of the factors propelling the global market within the U.S. are an increase in local companies undertaking R&D, a boost in the number of new products and FDA approvals, and increasing financing for the development of improved masks.
Will the United Kingdom Be a Lucrative Market for Surgical and Respiratory Masks?
“Need to control respiratory infections is driving the market in the country”
The United Kingdom market held around 11.5% market share of the global market in 2022.
This Guidelines overview, according to Medscape, describes the infection prevention and control (IPC) concepts necessary to stop the spread of COVID–19 and other respiratory viruses while minimizing the impact on health and care services.
To enable organizations to review and manage the continued delivery of service provision over the winter of 2021–2022, the guideline replaces the earlier UK IPC COVID–19 guidance for maintaining services within health and care settings. In addition to typical seasonal respiratory illnesses like the flu and respiratory syncytial virus, it takes into account SARS–CoV–2 (including variations of concern). As a result, the consideration for respiratory masks may arrive which aids the market growth.
How is China Emerging as a Prominent Market?
“Rise in hospitalization due to COVID–19 to promote the market in China”
China held a market share of about 9.8% of the global market in 2022.
The World Health Organisation (WHO) said on January 19 that China reported a 70% rise in weekly COVID hospitalizations, the highest since the pandemic started. According to the WHO's report based on data submitted by Beijing, the number of people hospitalized rose by 70 % to 63,307 versus the previous week, news agency Reuters reported.
However, the United Nations health agency said it was awaiting "detailed provincial data disaggregated by the week of reporting" on nearly 60,000 virus–related hospital deaths reported by China last week and did not include them in the tally. Hence, the demand for masks to protect from infection is booming in the market in China.
Which Product is Driving Demand within the Global Market?
“Accessible of basic surgical masks and potentiality to splash/fluid resistance”
The surgical mask segment held around 52.4% share of the total market in 2022.
Basic surgical masks are sold through several distribution channels and are conveniently available across hospitals and other pharmacies, retail outlets, and online distribution platforms. These masks provide basic protection to the wearer from the surrounding environment and are less expensive as compared to other surgical masks.
Fluid/splash–resistant surgical masks reduce potential exposure to blood and other body fluids caused by spattering, spray, or splashes during surgeries and medical procedures. They are intended for use in procedure rooms and cardiac labs, where a high level of protection from fluids is required. These masks provide barrier protection against respiratory droplets/splashes. Due to such factors, surgical masks are dominating the global market.
Which Usage is Adopted within the Global Market?
“Adoption of reusable masks due to its environmentally friendly nature”
Reusable masks held around 58.3% share of the total market in 2022.
Reusable masks are in demand due to their less damaging to the environment than single-use face masks. For instance, by comparing the reusable face mask to the environmental impact of single-use surgical face masks, it is evident which choice is more environmentally beneficial. Reusable surgical face masks will emit at least 30% fewer emissions for climate change and fossil fuel depletion than single-use surgical face masks, according to Life Cycle Assessment (LCA).
Which Distribution Channel is Widely Adopted?
“To increase product reach and the high volume sales”
Institutional sales held around 56.4% share of the total market in 2022.
The advantages of institutional sales include an outlet for medium and high-volume sales of surgical masks products. Manufacturers are turning to institutional sales to expand their product reach. Similarly the excessive use of surgical masks in institutions for example hospitals, laboratories, and ambulatory surgical centers. As a result, institutional sales are dominating the distribution channels for the market.
The businesses' main priorities are to increase production volume, improve their line of masks and respirators, introduce advanced features, and introduce new products. For accelerated and improved manufacturing, several businesses have purchased and worked with regional and global players.
Some key instances of development include:
|
Attribute |
Details |
|
Forecast Period |
2023–2033 |
|
Historical Data Available for |
2015–2022 |
|
Market Analysis |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Usage:
Distribution Channel:
Region:
The global market is currently valued at around US$ 3.57 Billion in 2022.
Sales of the market are set to witness growth at a CAGR of 8.1% and be valued at around US$ 8.4 Billion by 2033.
Demand for the global market increased at a 6.9% CAGR from 2015 – 2022.
The U.S., U.K., China, Japan, and Germany account for most demand within the market, currently holding around 63.7% market share.
The U.S. accounts for around 31.6% share of the North American market in 2022.
North America accounts for around 33.7% share of the global market in 2022.
The China market held a share of about 9.8% in the global market of surgical and respiratory masks in 2022.
The German market accounted for 4.7% market share in the global market.
The Japan market is expected to grow at a 5.9% CAGR during the forecast period.
In the global market of surgical and respiratory masks United Kingdom held for 11.5% market share in 2022.
